Published in Blood on May 15, 1992
RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 3.25
Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med (1994) 2.29
Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol (1995) 2.12
High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest (1997) 2.09
Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A (1994) 1.97
Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med (2012) 1.69
Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci U S A (1996) 1.58
Neurotrophins and the immune system. J Anat (2003) 1.46
Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med (1993) 1.46
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med (1997) 1.43
Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg (1999) 1.35
Revisiting the Koebner phenomenon: role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol (2008) 1.34
Role of nerve growth factor in cutaneous wound healing: accelerating effects in normal and healing-impaired diabetic mice. J Exp Med (1998) 1.17
IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A (1999) 1.15
Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med (1996) 1.12
Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc Natl Acad Sci U S A (1994) 1.11
Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut (1999) 1.10
Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol (1999) 1.08
Innate immunity. A Spaetzle-like role for nerve growth factor β in vertebrate immunity to Staphylococcus aureus. Science (2014) 0.99
Differential regulation of neurotrophin expression in human bronchial smooth muscle cells. Respir Res (2006) 0.98
Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci U S A (1993) 0.95
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc Natl Acad Sci U S A (1996) 0.88
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications. PLoS One (2015) 0.86
Disruption of antigen-induced airway inflammation and airway hyper-responsiveness in low affinity neurotrophin receptor p75 gene deficient mice. Br J Pharmacol (2001) 0.83
Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology (2000) 0.80
Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link. J Receptor Ligand Channel Res (2010) 0.77
Nerve growth factor: the dark side of the icon. Am J Pathol (2008) 0.76
Effects of terbutaline on NGF formation in allergic inflammation of the rat. Br J Pharmacol (2001) 0.76
Nerve growth factor: a neuroimmune crosstalk mediator for all seasons. Immunology (2017) 0.75
The Role of Nerve Growth Factor (NGF) and Its Precursor Forms in Oral Wound Healing. Int J Mol Sci (2017) 0.75
Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain. Mol Pain (2017) 0.75
RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 3.25
CC chemokines in allergic inflammation. Immunol Today (1994) 2.85
High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest (1997) 2.09
Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med (1992) 2.07
Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut (1999) 1.97
Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy (2004) 1.74
c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med (1992) 1.51
Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med (1989) 1.48
Role of cell surface contact in the kinetics of superoxide production by granulocytes. J Clin Invest (1983) 1.48
RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol (1993) 1.46
Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med (1993) 1.46
Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med (1990) 1.45
In vitro differentiation of near-unlimited numbers of functional mouse basophils using conditional Hoxb8. Allergy (2013) 1.43
Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med (1997) 1.43
Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci U S A (1983) 1.37
Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci U S A (1990) 1.30
Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines. J Immunol (1989) 1.27
Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol (1994) 1.27
The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig. J Immunol (1988) 1.26
IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J Immunol (1991) 1.20
Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol (1995) 1.18
Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med (1996) 1.12
Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood (1996) 1.11
Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. J Clin Invest (1991) 1.10
The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation. Eur J Immunol (1991) 1.09
Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. Proc Natl Acad Sci U S A (1985) 1.08
Robust expression of CCR3 as a single basophil selection marker in flow cytometry. Allergy (2011) 1.03
Human basophils release interleukin-4 after stimulation with Schistosoma mansoni egg antigen. Eur J Immunol (1996) 1.02
Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils. J Immunol (2000) 1.00
Activation of human basophils through the IL-8 receptor. J Immunol (1992) 0.97
Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Proc Natl Acad Sci U S A (1984) 0.96
The role of formylpeptide receptors, C5a receptors, and cytosolic-free calcium in neutrophil priming. J Infect Dis (1990) 0.95
Degranulation from human eosinophils stimulated with C3a and C5a. Int Arch Allergy Immunol (1994) 0.95
Circadian elevation of IL-6 levels in Muckle-Wells syndrome: a disorder of the neuro-immune axis? QJM (1998) 0.95
Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5. J Immunol (1991) 0.92
Complement-mediated arachidonate metabolism. Prog Biochem Pharmacol (1985) 0.91
Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Eur J Immunol (1996) 0.91
IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. Blood (1995) 0.90
Basophil priming by neurotrophic factors. Activation through the trk receptor. J Immunol (1996) 0.90
Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils. J Immunol (1984) 0.89
Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists. Eur J Immunol (1999) 0.89
Flowcytometric analysis of basophil counts in human blood and inaccuracy of hematology analyzers. Allergy (2005) 0.87
Interleukin 8-inhibitor and inducer of histamine and leukotriene release in human basophils. Biochem Biophys Res Commun (1991) 0.87
A single-photon imaging system for the simultaneous quantitation of luminescent emissions from multiple samples. Anal Biochem (1988) 0.84
Investigations on the role of Golgi-mediated, ligand-receptor processing in the activation of granulocytes by chemoattractants: differential effects of monensin. Biochim Biophys Acta (1987) 0.83
Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a. Biochem Biophys Res Commun (1991) 0.83
The degradation product of the C5a anaphylatoxin C5adesarg retains basophil-activating properties. Eur J Immunol (1994) 0.82
Signal transduction for interleukin-3-dependent leukotriene synthesis in normal human basophils: opposing role of tyrosine kinase and protein kinase. Eur J Immunol (1992) 0.81
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits. J Biol Chem (1985) 0.81
IL-33 is a mediator rather than a trigger of the acute allergic response in humans. Allergy (2013) 0.81
Increased coexpression of eotaxin and interleukin 5 in bullous pemphigoid. Acta Derm Venereol (2001) 0.80
Bird-egg syndrome. Cross-reactivity between bird antigens and egg-yolk livetins in IgE-mediated hypersensitivity. Int Arch Allergy Appl Immunol (1988) 0.80
Opposing effects of tumor necrosis factor-alpha and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine. Eur J Immunol (1992) 0.79
Nerve growth factor from the venom of the Chinese cobra Naja naja atra: purification and description of non-neuronal activities. Toxicon (1995) 0.79
Effect of structural modification at carbon atom 1 of leukotriene B4 on the chemotactic and metabolic response of human neutrophils. Anal Biochem (1987) 0.79
In human basophils, IL-3 selectively induces RANKL expression that is modulated by IgER-dependent and IgER-independent stimuli. Allergy (2014) 0.78
Studies on the mechanism of platelet-activating factor production in GM-CSF primed neutrophils: involvement of protein synthesis and phospholipase A2 activation. Biochem Biophys Res Commun (1990) 0.78
Allergic reaction to snake venom after repeated bites of Vipera aspis. Clin Exp Allergy (1993) 0.78
Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma. Int Arch Allergy Immunol (1996) 0.78
Functional reconstitution of a receptor-activated signal transduction pathway in Xenopus laevis oocytes using the cloned human C5a receptor. Cell Signal (1992) 0.78
Sulfidoleukotriene generation from peripheral blood leukocytes of horses affected with insect bite dermal hypersensitivity. Vet Immunol Immunopathol (1999) 0.77
Basophil and eosinophil activation by CC chemokines. Int Arch Allergy Immunol (1995) 0.77
The multiple role of cytokines in IgE-mediated allergic reactions. Behring Inst Mitt (1992) 0.76
[Immunotherapy of asthma: pro and contra]. Ther Umsch (1992) 0.75
New perspectives in the modulation of allergic inflammation. Int Arch Allergy Appl Immunol (1989) 0.75
Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils. Int Arch Allergy Immunol (1995) 0.75
[New perspectives in the modulation of allergic inflammation]. Z Hautkr (1990) 0.75
Release and metabolism of leukotriene A4 in neutrophil-mast cell interactions. Methods Enzymol (1990) 0.75
Immunolocalization of intracellular interleukin-4 in normal human peripheral blood basophils. Eur J Immunol (1994) 0.75
Peptide analogues of consensus receptor sequence inhibit the action of cytokines on human basophils. Lymphokine Cytokine Res (1992) 0.75